Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells.

Le Bail JC, Champavier Y, Chulia AJ, Habrioux G.

Life Sci. 2000 Feb 25;66(14):1281-91.

PMID:
10755463
2.

Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.

Pasqualini JR, Chetrite GS.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):221-36. Review.

PMID:
15860265
3.

Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.

Aka JA, Mazumdar M, Lin SX.

Mol Cell Endocrinol. 2009 Mar 25;301(1-2):183-90. doi: 10.1016/j.mce.2008.10.042. Epub 2008 Nov 7. Review.

PMID:
19038308
4.

Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Brozic P, Lanisnik Risner T, Gobec S.

Curr Med Chem. 2008;15(2):137-50. Review.

PMID:
18220769
5.

New development in intracrinology of breast carcinoma.

Sasano H, Suzuki T, Nakata T, Moriya T.

Breast Cancer. 2006;13(2):129-36. Review.

6.

Phytoestrogens and prostate cancer.

Morrissey C, Watson RW.

Curr Drug Targets. 2003 Apr;4(3):231-41. Review.

PMID:
12643473
7.

The selective estrogen enzyme modulator (SEEM) in breast cancer.

Chetrite GS, Pasqualini JR.

J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):95-104. Review.

PMID:
11384867
8.

Natural modulators of estrogen biosynthesis and function as chemopreventive agents.

Bhat KP, Pezzuto JM.

Arch Pharm Res. 2001 Dec;24(6):473-84. Review.

PMID:
11794520
9.

17beta-hydroxysteroid dehydrogenases in human breast cancer.

Nagasaki S, Miki Y, Akahira J, Suzuki T, Sasano H.

Ann N Y Acad Sci. 2009 Feb;1155:25-32. doi: 10.1111/j.1749-6632.2008.03682.x. Review.

PMID:
19250189
10.

Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.

Shields-Botella J, Chetrite G, Meschi S, Pasqualini JR.

J Steroid Biochem Mol Biol. 2005 Jan;93(1):1-13. Epub 2005 Jan 26. Review.

PMID:
15748827
11.

Phytoestrogens: recent developments.

Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ.

Planta Med. 2003 Jul;69(7):589-99. Review.

PMID:
12898412
12.

Steroid metabolism in breast cancer.

Foster PA.

Minerva Endocrinol. 2008 Mar;33(1):27-37. Review.

13.

[Phytoestrogens: potential agents for prevention and treatment of breast cancer. 2. Estrogenic and antiestrogenic plant substances].

Otto AM.

Pharm Unserer Zeit. 2000 Mar;29(2):91-9. Review. German. No abstract available.

PMID:
10763334
14.

Inhibitors of 17 beta-hydroxysteroid dehydrogenases.

Poirier D.

Curr Med Chem. 2003 Mar;10(6):453-77. Review.

PMID:
12570693
15.

Phytoestrogens after breast cancer.

This P, De La Rochefordière A, Clough K, Fourquet A, Magdelenat H; Breast Cancer Group of the Institut Curie.

Endocr Relat Cancer. 2001 Jun;8(2):129-34. Review.

16.

Phytoestrogens and breast cancer risk. Review of the epidemiological evidence.

Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE.

Breast Cancer Res Treat. 2003 Jan;77(2):171-83. Review.

PMID:
12602916
17.

Progestins and breast cancer.

Pasqualini JR.

Gynecol Endocrinol. 2007 Oct;23 Suppl 1:32-41. Review.

PMID:
17943537
18.

Phytoestrogens: the "natural" selective estrogen receptor modulators?

Brzezinski A, Debi A.

Eur J Obstet Gynecol Reprod Biol. 1999 Jul;85(1):47-51. Review.

PMID:
10428321
19.

Phytoestrogens in health and disease.

Davis SR, Dalais FS, Simpson ER, Murkies AL.

Recent Prog Horm Res. 1999;54:185-210; discussion 210-1. Review.

PMID:
10548876
20.

Reproductive actions of phytoestrogens.

Whitten PL, Naftolin F.

Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):667-90. Review.

PMID:
10384819

Supplemental Content

Support Center